Lung cancer drug 'could prevent metastases spreading'

News

Lung cancer drug 'could prevent metastases spreading'

25 Feb, 2011

Published over 15 years ago. See the latest and most current information on News.

Scientists have discovered a lung cancer drug could have a duel purpose in tackling the condition.

Dr Michela Quirino and colleagues from the Catholic University of the Sacred Heart in Rome announced the laboratory news after investigating how zoledronic acid may be able to prevent the cancer from spreading.

Currently, the drug is used to help treat bone metastases but the study suggests it may also be useful in the initial stages of the disease.

Dr Quirino said: "If further studies should confirm a possible anti-metastatic effect of this drug ... it could be introduced in the early management of the disease, even as an adjuvant therapy."

The expert conducted a trial on 41 patients with advanced lung cancer and concluded that the evidence implies zoledronic acid may prevent the metastases from recruiting the blood vessels they need to survive.

Zoledronic acid is also used to treat high levels of calcium in the blood.
 

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Autosampler probe reduces blockage risk and improves sample flow stability in ICP systems
Explore more Arrow
Pollution Solutions Online
Next-generation reverse osmosis membranes for more efficient and cost-effective seawater desalination
Explore more Arrow
Petro Online
Free webinar: enhancing accuracy and efficiency in renewable fuel laboratory testing
Explore more Arrow
Chromatography Today
Chromatography and XFEL imaging reveal critical point behind water’s behaviour
Explore more Arrow